{"title":"Buprenorphine in pregnancy improves health of mom and newborn","authors":"Alison Knopf","doi":"10.1002/adaw.34539","DOIUrl":null,"url":null,"abstract":"<p>Opioid use disorder (OUD) in pregnancy is a serious problem, but buprenorphine and methadone, medications which treat the disorder, both improve outcomes for mothers and their children. Researchers conducted a retrospective cohort study of Medicaid Tennessee pregnant patients, and found buprenorphine compared to no treatment improved outcomes. For the study, “Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes,” published in <i>JAMA Health Forum</i> April 27, the researchers followed 14,463 maternal-infant dyads continuously enrolled in the Tennessee Medicaid program from 20 weeks' estimated gestational age to 6 weeks post-partum between 2010 and 2021.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":"4-6"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34539","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Opioid use disorder (OUD) in pregnancy is a serious problem, but buprenorphine and methadone, medications which treat the disorder, both improve outcomes for mothers and their children. Researchers conducted a retrospective cohort study of Medicaid Tennessee pregnant patients, and found buprenorphine compared to no treatment improved outcomes. For the study, “Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes,” published in JAMA Health Forum April 27, the researchers followed 14,463 maternal-infant dyads continuously enrolled in the Tennessee Medicaid program from 20 weeks' estimated gestational age to 6 weeks post-partum between 2010 and 2021.